Follow the people · Insider
Alisha Charlton
Alisha Charlton files insider transactions with the SEC as a chief financial officer of Pro Dex. We hold 1 disclosed purchase or sale filed since 18 December 2008, 1 of them in the last 90 days.
- Files for 2 companiesPDEX, CMRO
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 August 2015 — 9 September 2026Chief Financial Officer · Pro Dex 37 Form 4 lines · source: SEC Form 4
- Filed 16 December 2008 — 8 October 2013VP, Chief Accounting Officer · Comarco 6 Form 4 lines · source: SEC Form 4
Every transaction
43 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | sold on the open market | Pro Dex | 1,500 shares | up +3.5% | up +5.0% |
| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | sold on the open market | Pro Dex | 800 shares | up +3.5% | up +5.0% |
| 1 Jul 2026 | 6 Jul 2026SEC Form 4 | 5 d | was grantednot a trade | Pro Dex | 10,800 shares | up +0.1% | up +1.6% |
| 1 Jul 2026 | 6 Jul 2026SEC Form 4 | 5 d | had shares withheld for taxnot a trade | Pro Dex | 3,897 shares | up +0.1% | up +1.6% |
| 20 Nov 2025 | 21 Nov 2025SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Pro Dex | 72 shares | up +103.7% | up +92.3% |
| 20 Nov 2025 | 21 Nov 2025SEC Form 4 | 1 d | was grantednot a trade | Pro Dex | 1,000 shares | up +103.7% | up +92.3% |
| 20 Nov 2024 | 22 Nov 2024SEC Form 4 | 2 d | was grantednot a trade | Pro Dex | 1,000 shares | up +31.9% | up +34.3% |
| 7 Nov 2024 | 8 Nov 2024SEC Form 4 | 1 d | sold on the open market | Pro Dex | 1,000 shares | up +52.8% | up +47.2% |
| 1 Jul 2024 | 3 Jul 2024SEC Form 4 | 2 d | was grantednot a trade | Pro Dex | 10,800 shares | up +242.3% | up +266.6% |
| 1 Jul 2024 | 3 Jul 2024SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Pro Dex | 3,938 shares | up +242.3% | up +266.6% |
| 14 Jul 2022 | 8 Aug 2022SEC Form 4 | 25 d | was grantednot a trade | Pro Dex | 7,300 shares | up +298.5% | up +288.6% |
| 14 Jul 2022 | 8 Aug 2022SEC Form 4 | 25 d | had shares withheld for taxnot a trade | Pro Dex | 2,597 shares | up +298.5% | up +288.6% |
| 21 Dec 2021 | 23 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 1,000 shares | up +173.1% | up +166.1% |
| 21 Dec 2021 | 23 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 1,000 shares | up +173.1% | up +166.1% |
| 21 Dec 2021 | 23 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 1,000 shares | up +173.1% | up +166.1% |
| 21 Dec 2021 | 23 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 1,000 shares | up +173.1% | up +166.1% |
| 21 Dec 2021 | 23 Dec 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 1,000 shares | up +173.1% | up +166.1% |
| 25 May 2021 | 25 May 2021SEC Form 4 | 0 d | sold on the open market | Pro Dex | 978 shares | up +86.1% | up +86.1% |
| 23 Feb 2021 | 25 Feb 2021SEC Form 4 | 2 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +151.7% | up +137.4% |
| 7 Dec 2020 | 28 Jan 2021SEC Form 4 | 52 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +61.2% | up +96.9% |
| 7 Dec 2020 | 28 Jan 2021SEC Form 4 | 52 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +61.2% | up +96.9% |
| 7 Dec 2020 | 28 Jan 2021SEC Form 4 | 52 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +61.2% | up +96.9% |
| 7 Dec 2020 | 28 Jan 2021SEC Form 4 | 52 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +61.2% | up +96.9% |
| 7 Dec 2020 | 28 Jan 2021SEC Form 4 | 52 d | was grantednot a trade | Pro Dexderivative | 4,250 shares | up +61.2% | up +96.9% |
| 15 Sep 2020 | 16 Sep 2020SEC Form 4 | 1 d | sold on the open market | Pro Dex | 1,500 shares | up +105.8% | up +106.5% |
| 16 Jul 2020 | 17 Jul 2020SEC Form 4 | 1 d | was grantednot a trade | Pro Dex | 7,300 shares | up +231.4% | up +224.7% |
| 16 Jul 2020 | 17 Jul 2020SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Pro Dex | 2,526 shares | up +231.4% | up +224.7% |
| 12 Feb 2020 | 12 Feb 2020SEC Form 4 | 0 d | sold on the open market | Pro Dex | 2,300 shares | up +225.4% | up +225.4% |
| 13 Feb 2019 | 13 Feb 2019SEC Form 4 | 0 d | sold on the open market | Pro Dex | 2,114 shares | up +314.6% | up +314.6% |
| 1 Jul 2018 | 2 Jul 2018SEC Form 4 | 1 d | was grantednot a trade | Pro Dex | 7,300 shares | up +844.4% | up +851.6% |
| 1 Jul 2018 | 2 Jul 2018SEC Form 4 | 1 d | had shares withheld for taxnot a trade | Pro Dex | 2,741 shares | up +844.4% | up +851.6% |
| 1 Feb 2018 | 2 Jul 2018SEC Form 4 | 151 d | acquired or disposed of, othernot a trade | Pro Dex | 219 shares | up +844.4% | up +851.6% |
| 3 Aug 2017 | 2 Jul 2018SEC Form 4 | 333 d | acquired or disposed of, othernot a trade | Pro Dex | 249 shares | up +938.1% | up +851.6% |
| 2 Feb 2017 | 2 Jul 2018SEC Form 4 | 515 d | acquired or disposed of, othernot a trade | Pro Dex | 286 shares | up +1096.3% | up +851.6% |
| 4 Aug 2016 | 2 Jul 2018SEC Form 4 | 697 d | acquired or disposed of, othernot a trade | Pro Dex | 264 shares | up +1129.1% | up +851.6% |
| 30 Jan 2016 | 2 Jul 2018SEC Form 4 | 884 d | acquired or disposed of, othernot a trade | Pro Dex | 662 shares | up +2618.8% | up +851.6% |
| 1 Aug 2015 | 2 Jul 2018SEC Form 4 | 1066 d | acquired or disposed of, othernot a trade | Pro Dex | 653 shares | up +2595.5% | up +851.6% |
| 8 Oct 2013 | 10 Oct 2013SEC Form 4 | 2 d | was grantednot a trade | Comarco | 30,000 shares | — | — |
| 31 Jan 2013 | 21 Feb 2013SEC Form 4 | 21 d | had shares withheld for taxnot a trade | Comarco | 16,100 shares | — | — |
| 5 Jul 2012 | 21 Feb 2013SEC Form 4 | 231 d | had shares withheld for taxnot a trade | Comarco | 11,475 shares | — | — |
| 1 Feb 2012 | 3 Feb 2012SEC Form 4 | 2 d | was grantednot a trade | Comarco | 40,000 shares | — | — |
| 5 Jul 2011 | 6 Jul 2011SEC Form 4 | 1 d | was grantednot a trade | Comarco | 30,000 shares | — | — |
| 16 Dec 2008 | 18 Dec 2008SEC Form 4 | 2 d | was grantednot a trade | Comarcoderivative | 18,500 shares | — | — |
Both percentages are the stock’s move, not Alisha Charlton’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 37 of the 43 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.